Page last updated: 2024-09-03

lvv-hemorphin-7 and leucine

lvv-hemorphin-7 has been researched along with leucine in 1 studies

Compound Research Comparison

Studies (lvv-hemorphin-7)	Trials (lvv-hemorphin-7)	Recent Studies (post-2010) (lvv-hemorphin-7)	Studies (leucine)	Trials (leucine)	Recent Studies (post-2010) (leucine)
59	0	14	28,515	744	4,178

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S	1

Other Studies

1 other study(ies) available for lvv-hemorphin-7 and leucine

Article	Year
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). Journal of neurochemistry, 2003, Volume: 86, Issue:2 Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity	2003

Article

Year

Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).

Journal of neurochemistry, 2003, Volume: 86, Issue:2

Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity

2003